An Ayurvedic Management of Prameha Upadrava Vis-a-Vis Diabetic Sensory Neuropathy with Madhutailika Basti

Evaluation of the Efficacy of Madhutailika Basti in Prameha Upadrava Vis-a-Vis Diabetic Sensory Neuropathy- An Open Label Single Arm Interventional Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056969

Enrollment

Registered

2023-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E084- Diabetes mellitus due to underlying condition with neurological complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with both Type-1 and Type-2 Diabetes Mellitus having features ofDaha(Burning sensation), Harsha(Tingling sensation), Suptata(Numbness). 2.Both freshly detected and treated cases of Diabetic Neuropathy. 3.Those who are under medication for Diabetic Neuropathy. 4.Subjects of either gender between the age group of 20-70years will be selected. 5.Subjects fit for Basti karma are selected

Exclusion criteria

Exclusion criteria: 1.Subjects with other systemic diseases which would interfere with the course of treatment will be excluded like Coronary artery disease, Peripheral artery disease etc. 2.Subjects with controlled and uncontrolled Diabetes Mellitus i,e FBS >300mg/dl PPBS >350mg/dl and HbA1c above 9% will be excluded. 3.Subjects with Neuropathies secondary to causes other than Diabetes such as Alcoholism, Drug abuse, Vitamin B12 deficiency, Cirrhosis of the liver, Hepatitis, Renal insufficiency will be excluded. 4.Subjects with other complications of Diabetes Mellitus like Diabetic Nephropathy, Infectious wounds,Gangrene and Foot ulcers will be excluded. 5.Pregnant women & lactating mothers.

Design outcomes

Primary

Measure	Time frame
Effect of Madhutailika Basti in reduction of sings and symptoms of Prameha Upadrava sush as Daha Suptata and HarshaTimepoint: 0th day- before treatment 9th day- after basti 25th day- after treatment	—

Secondary

Measure	Time frame
Effect of Madhutailika Basti in reduction of sings & symptoms of Prameha Upadrava sush as Daha Suptata & HarshaTimepoint: 25 days	—

Countries

India

Contacts

Public ContactDr Seetha Devi P

JSS Ayurveda Medical College and Hospital

drsitadevi@gmail.com8431444499

Outcome results